The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Diversity-oriented synthesis: exploring the intersections between chemistry and biology
Abstract
Diversity-oriented synthesis (DOS) is an emerging field involving the synthesis of combinatorial libraries of diverse small molecules for biological screening. Rather than being directed toward a single biological target, DOS libraries can be used to identify new ligands for a variety of targets. Several different strategies for library design have been developed to target the biologically relevant regions of chemical structure space. DOS has provided powerful probes to investigate biological mechanisms and also served as a new driving force for advancing synthetic organic chemistry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Good biocompatibility also ensures that there is no inflammatory reaction in the surrounding tissue due to rejection after it enters the human body [75,76,77].”
From Synthesis and Biological Application of Polylactic Acid (2020) · cites this paper as [77]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 1×
“Furthermore, because synthetic drugs are most useful when orally bioavailable, numerous studies have aimed at identifying physicochemical properties that correlate with this characteristi”
BackgroundSolid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150 · cited 1×
“In addition to traditional 'wet' screening, in silico 'virtual' screening has also been used to identify new ligands and ligand fragment”
MethodErtl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“Notably, despite the tremendous impact that natural products have historically had on drug discover”
BackgroundThe Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
Horton, D. A., Bourne, G. T., & Smythe, M. L. (2003) · Chemical Reviews · doi:10.1021/cr020033s · Cited by 3,013 · cited 1×
“These common drug scaffolds often serve as the basis for DOS of 'drug-like' librarie”
BackgroundHDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 1×
“Tubacin proved to be a particularly valuable tool for studying HDAC6, an α-tubulin deacetylase with two catalytic domain”
BackgroundSynthesis and Applications of Supramolecular-Templated Mesoporous Materials
Ying, J. Y., Mehnert, C. P., & Wong, M. S. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990115)38:1/2<56::aid-anie56>3.0.co;2-e · Cited by 2,030
Cited by
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Privileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Hybrid Molecules with a Dual Mode of Action: Dream or Reality?
Meunier, B. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000843 · Cited by 929
Galloway, W. R. J. D., Isidro-Llobet, A., & Spring, D. R. (2010) · Nature Communications · doi:10.1038/ncomms1081 · Cited by 891
“Traditionally, when a specific biological molecule or family of molecules is targeted, the compounds used in the screening process are usually selected or designed on the basis of knowledge of the target structure or the structure of known natural ligand”
BackgroundBanaszynski, L. A., Chen, L.-C., Maynard-Smith, L. A., Ooi, A. G. L., & Wandless, T. J. (2006) · Cell · doi:10.1016/j.cell.2006.07.025 · Cited by 902
“Recently, investigators screening libraries of synthetic small molecules have discovered inhibitors for several proteins of interest (Mayer et al., 1999; Tan, 2005).”
Metadata
- Authors
- Tan, D. S.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Tan, Derek S
- ORCID
- Tan, Derek S
- Venue
- Nature Chemical Biology
- Published
- 2005-07
- Volume
- 1
- Issue
- 2
- Pages
- 74-84
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2069601502
- Cited by
- 605
- References
- 88
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 14 · 2023: 11 · 2022: 10 · 2021: 18 · 2020: 17 · 2019: 25 · 2018: 28 · 2017: 24 · 2016: 34 · 2015: 35 · 2014: 45 · 2013: 53 · 2012: 51
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R21CA104685, CA104685)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- diversity-oriented synthesis, combinatorial libraries, small molecules, biological screening, ligand discovery, library design, organic synthesis, biological mechanisms
- MeSH terms
- Animals, Biology, Chemistry, Organic, Proteins, Drug Design, Signal Transduction, Combinatorial Chemistry Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diversity-oriented synthesis: exploring the intersections between chemistry and biology. https://app.cochat.ai/papers/10.1038/nchembio0705-74
- The paper
- Tan, D. S. (2005). Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nature Chemical Biology. https://doi.org/10.1038/nchembio0705-74
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.